Aptys Pharma is pleased to announce that Chloé Hodonou is now the new head of formulation and design activity

“Chloé Hodonou started at Aptys as formulation scientist and project leader. Throughout the many projects she managed, Chloé Hodonou was extremely open-minded to propose more and more innovating formulations and solutions to our clients.
There is no doubt that her determination as well as her expertise will be great assets to succeed in her new responsibilities including the management of the resources in order to achieve her different missions.” underlines François Boutignon, Aptys Pharma’s President.